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Available online 3 December 2015The KCL016 human embryonic stem cell line was derived from an embryo donated for research that carried an
autosomal dominant mutation affecting splicing site of the VHL gene encoding von Hippel–Lindau tumor sup-
pressor E3 ubiquitin protein ligase (676 + 3A N T). The ICM was isolated using laser microsurgery and plated
on γ-irradiated human foreskin ﬁbroblasts. Both the derivation and cell line propagation were performed in an
animal product-free environment. Pluripotent state and differentiation potential were conﬁrmed by in vitro
assays.
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established previously (Ilic et al., 2012; Stephenson et al., 2012). The ex-
pression of the pluripotencymarkers was tested after freeze/thaw cycle
(Fig. 2). Differentiation potential into three germ layers was veriﬁed
in vitro (Fig. 3).
Molecular karyotyping identiﬁed an imbalance on chromosome
8p23.1 (7,256,229–7,729,370) that was not present in either of two sib-
ling cell lines, KCL015 and KCL017. Imbalance in this region has been
found in normal individuals and is established as benign copy number
variation.Fig. 1. Genetic pedigree tree of the couple undergoing PGD for the VHL syndrome.
3. Materials and methods
3.1. Consenting process
We distribute Patient Information Sheet (PIS) and consent form to
the in vitro fertilization (IVF) patients if they opted to donate to research
embryos that were stored for 5 or 10 years. They mail signed consent
back to us and that might be months after the PIS and consent were
mailed to them. If in the meantime new versions of PIS/consent are im-
plemented, we do not send these to the patients or ask them to re-sign;
thewhole process is donewith the version thatwas given them initially.
The PIS/consent documents (PGD-V.6) were created on Aug. 10, 2007.
HFEA Code of Practice was in effect at the time of document creation:
Edition 7— R.1 (http://www.hfea.gov.uk/2999.html). The donor couple
signed the consent on Aug. 12, 2009. HFEA Code of Practice was in effect
at the time of donor signature: Edition 7 — R.4. HFEA Code of Practice
Edition 7 — R.1 was in effect until 09 Dec. 2007 and Edition 7 — R.4
was in effect: 02 Oct. 2008–30 Sep. 2009.3.2. Embryo culture and micromanipulation
Embryo culture and laser-assisted dissection of inner cell mass
(ICM) were carried out as previously described in details (Ilic et al.,
2012; Stephenson et al., 2012). The cellular area containing the ICM
was then washed and transferred to plates containing mitotically
inactivated human neonatal foreskin ﬁbroblasts (HFF).peciﬁc for chromosomes 13, 18, 21, X and Ywere am-
ers on chromosomes 13, 18, and 21 are listed in the
Allele 1 Allele 2
294 298
443 459
288 292
453 453
403 415
375 390
372 380
217 217
478 486
416 420
480 483
215 219
244 248
214 227
311 319
184 184
331 3313.3. Cell culture
ICM plated onmitotically inactivated HFF was cultured as described
(Ilic et al., 2012; Stephenson et al., 2012). TE cells were removed me-
chanically from outgrowth (Ilic et al., 2007, 2010). hES colonies were
expanded and cryopreserved at the third passage.3.4. Viability test
Straws with the earliest frozen passage (p.2-3) are thawed and new
colonies are counted three days later. These colonies are then expanded
up to passage 8, atwhich point cellswere part frozen and part subjected
to standard battery of tests (pluripotency markers, in vitro and in vivo
differentiation capability, genetics, sterility, mycoplasma).3.5. Pluripotency markers
Pluripotencywas assessed using two different techniques: enzymat-
ic activity assay [alkaline phosphatase (AP) assay] and immunostaining
as described (Ilic et al., 2012; Stephenson et al., 2012).Fig. 2. Expression of pluripotency markers. Pluripotency is conﬁrmed by immunostaining
(Oct4, Nanog, TRA-1-60, TRA-1-81) and alkaline phosphatase (AP) activity assay. Actin
stress ﬁbers, visualized with rhodamine–phalloidin (red), are present in both feeders
and hES cell colonies, whereas AP activity (green) is detected only in hES cells. Scale bar,
100 μm.
Fig. 3.Differentiation of three germ layers in vitro is conﬁrmed by detection of markers: smoothmuscle actin (red) formesoderm, β-III tubulin (red) for ectoderm andα-fetoprotein (red)
for endoderm. Nuclei are visualized with Hoechst 33342 (blue). Scale bar, 100 μm.
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DNA was extracted from hES cell cultures using a Chemagen DNA
extraction robot according to the manufacturer's instructions. Ampliﬁ-
cation of polymorphic microsatellite markers was carried out as de-
scribed (Ilic et al., 2012). Allele sizes were recorded to give a unique
ﬁngerprint of each cell line.
3.7. Array comparative genomic hybridization (aCGH)
aCGH was performed as described in details (Ilic et al., 2012).
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